Akèy › Limfòm selil B › Missouri › Kansas City

Etid klinik pou Limfòm selil B nan Kansas City, MO

5 etid pou Limfòm selil B ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

Ap rekriteFaz 1/2

The University of Kansas Cancer Center, Westwood · 5 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06634589

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Ap rekriteFaz 3

University of Kansas Cancer Center, Westwood · 5 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

Ap rekriteFaz 2

University of Kansas Cancer Center, Westwood · 5 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT04792489

Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies

Ap rekriteFaz 1

University of Kansas Cancer Center, Westwood · 5 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT06879340

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Ap rekriteFaz 1/2

University of Kansas, Westwood · 5 mi lwen

Laj 18 ak plis · Tout sèks · Mizajou Nov 14, 2025 · NCT05643742

Etid Limfòm selil B nan lòt vil

Lòt etid nan Kansas City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.